Authors
Loading...
Randomized trial shows that Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects, indicating a potential treatment approach.
Santomauro et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: